Why Hims & Hers Health and LifeMD Are Skyrocketing Today

Shares of Hims & Hers Health (NYSE: HIMS) and LifeMD (NASDAQ: LFMD) are surging on Tuesday. The companie' stocks had jumped 24% and 34%, respectively, as of 3:15 p.m. ET as the S&P 500 and the Nasdaq Composite showed modest gains.Shares soared after pharma giant Novo Nordisk announced it will distribute its blockbuster GLP-1 weight loss drug Wegovy through telehealth platforms like Hims & Hers and LifeMD.Novo Nordisk announced it will sell Wegovy directly through telehealth providers including Hims & Hers Health, LifeMD, and Ro, making it easier for patients to access the uber-popular anti-obesity drug. The drugmaker resolved an earlier supply shortage and is now pushing to expand its reach. Customers will be able to access Novo's direct to consumer pharmacy, NovoCare, through Hims & Hers, LifeMD, and peers.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool